Corporate ProfileNantHealth is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth‘s unique systems-based approach to personalized healthcare integrates novel diagnostics with large-scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. In addition, NantHealth’s adaptive learning system, CLINICS, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.
Stock Quote NH (Common Stock) $3.070.00 (0.00%)
Today's Open$3.06
Previous Close$3.07
Data as of 07/23/18 1:06 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: NH.O.  Currently trading at $3.07 with a 52 week high of $5.26 and a 52 week low of $2.60.
Recent News

June 20, 2018

NantHealth Unveils New Collaboration Tools - Provider Initiated Document Exchange and Authorization Appeals

Further Enhancing NaviNet Open’s Ability to Tackle Payer-Provider Communication Challenges LOS ANGELES--(BUSINESS WIRE)--Jun. 20, 2018-- NantHealth, Inc. (NASDAQ: NH) announced two exciting new product launches - Provider Initiated Document Exchange and Authorization Appeals - on the nation’s leading payer-provider collaboration platform, NaviNet® Open, at the 2018 AHIP Institute and Expo. Today, the exchange of information betw...

Read More >

June 19, 2018

NantHealth to Present and Exhibit on the Convergence of Precision Medicine and Value-Based Care at America’s Health Insurance Plans (AHIP) Institute & Expo 2018

CULVER CITY, Calif. & SAN DIEGO--(BUSINESS WIRE)--Jun. 19, 2018-- NantHealth (NASDAQ: NH), a next-generation healthcare company, will exhibit and present at America’s Health Insurance Plans (AHIP) Institute & Expo 2018 taking place June 20-22, 2018 at the San Diego Convention Center in San Diego, CA at booth #824. NantHealth, a Silver-Sponsor at the AHIP Institute & Expo 2018, will showcase its health IT and precision medicine ...

Read More >

June 02, 2018

NantHealth Unveils Liquid GPS™, Powerful Next-Generation Tool for Blood-Based Tumor Profiling and Quantitative Monitoring

Molecular test allows for continuous, noninvasive monitoring and tumor profiling CHICAGO--(BUSINESS WIRE)--Jun. 2, 2018-- NantHealth, Inc. (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company, unveiled Liquid GPS™ a powerful next-generation tool for blood-based tumor profiling and quantitative monitoring. NantHealth chose the American Society of Clinical Oncology (ASCO) 2018 Annual Meet...

Read More >

Upcoming Events
There are currently no events scheduled.